{"id":25187,"date":"2025-04-01T13:57:43","date_gmt":"2025-04-01T13:57:43","guid":{"rendered":"https:\/\/www.euforea.org\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/"},"modified":"2026-08-20T07:56:57","modified_gmt":"2026-08-20T07:56:57","slug":"remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/","title":{"rendered":"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"25187\" class=\"elementor elementor-25187 elementor-14712\" data-elementor-post-type=\"news\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0b3eb1b e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"0b3eb1b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d3cd1d5 elementor-widget elementor-widget-euforea_general_content\" data-id=\"d3cd1d5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_content.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n    <div data-quickedit-entity-id=\"paragraph\/842\" class=\"paragraph paragraph--text-columns paragraph-id--842 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n      <div class=\"inner--wide\">\n        <div class=\"text__text text text--paragraph\">\n        \t          <p>La r\u00e9mission a r\u00e9cemment \u00e9t\u00e9 propos\u00e9e comme nouvel objectif de prise en charge de la RSCaPN, ou syndrome des polypes nasaux, par l\u2019EUFOREA \/ le document de r\u00e9f\u00e9rence europ\u00e9en sur la rhinosinusite et les polypes nasaux (EUFOREA\/EPOS), ainsi que par des leaders mondiaux en rhinologie. Dans la RSCaPN, la r\u00e9mission est d\u00e9finie comme un \u00e9tat prolong\u00e9 de contr\u00f4le, sans sympt\u00f4mes g\u00eanants rapport\u00e9s par le patient pendant au moins 12 mois, sans recours aux corticost\u00e9ro\u00efdes oraux ni \u00e0 la chirurgie endoscopique des sinus (ESS), et sans signes endoscopiques de maladie active. <\/p>\n<p>Ce nouvel objectif de prise en charge doit \u00eatre encourag\u00e9 par la communaut\u00e9 ORL et les patients atteints de RSCaPN, car des sympt\u00f4mes persistants non soulag\u00e9s par les approches historiques peuvent \u00eatre r\u00e9duits gr\u00e2ce \u00e0 de nouvelles th\u00e9rapies, notamment les bioth\u00e9rapies. L\u2019objectif du traitement de la RSCaPN a longtemps \u00e9t\u00e9 d\u2019atteindre le contr\u00f4le, les scores de l\u2019\u00e9chelle visuelle analogique (EVA) et du Sino-Nasal Outcome Test (SNOT-22) guidant les m\u00e9decins vers un traitement progressif visant le contr\u00f4le. <\/p>\n<p><strong>Co-auteurs :<\/strong> Peter Hellings. Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior <\/p>\n        <\/div>\n      <\/div>\n    <\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7182727 elementor-widget elementor-widget-euforea_general_hover\" data-id=\"7182727\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_hover.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n\t\t\t\t<div class=\"inner--wide\">\n\t\t\t<div class=\"text__text text text--paragraph\">\t\t\n\t\t\t\t<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=3267\" target=\"_blank\">\n\t\t\t\t\t<strong>Acc\u00e8s libre en rhinologie<\/strong><\/a><\/span>\n\t\t\t\t<\/p>\t\t\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>La r\u00e9mission a r\u00e9cemment \u00e9t\u00e9 propos\u00e9e comme nouvel objectif de prise en charge de la RSCaPN, ou syndrome des polypes nasaux, par l\u2019EUFOREA \/ le document de r\u00e9f\u00e9rence europ\u00e9en sur la rhinosinusite et les polypes nasaux (EUFOREA\/EPOS), ainsi que par des leaders mondiaux en rhinologie. Dans la RSCaPN, la r\u00e9mission est d\u00e9finie comme un \u00e9tat prolong\u00e9 de contr\u00f4le, sans sympt\u00f4mes g\u00eanants rapport\u00e9s par le patient pendant au moins 12 mois, sans recours aux corticost\u00e9ro\u00efdes oraux ni \u00e0 la chirurgie endoscopique des sinus (ESS), et sans signes endoscopiques de maladie active. Ce nouvel objectif de prise en charge doit \u00eatre encourag\u00e9 par la communaut\u00e9 ORL et les patients atteints de RSCaPN, car des sympt\u00f4mes persistants non soulag\u00e9s par les approches historiques peuvent \u00eatre r\u00e9duits gr\u00e2ce \u00e0 de nouvelles th\u00e9rapies, notamment les bioth\u00e9rapies. L\u2019objectif du traitement de la RSCaPN a longtemps \u00e9t\u00e9 d\u2019atteindre le contr\u00f4le, les scores de l\u2019\u00e9chelle visuelle analogique (EVA) et du Sino-Nasal Outcome Test (SNOT-22) guidant les m\u00e9decins vers un traitement progressif visant le contr\u00f4le. Co-auteurs : Peter Hellings. Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Acc\u00e8s libre en rhinologie<\/p>\n","protected":false},"author":9,"featured_media":25189,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[266],"tags":[],"class_list":["post-25187","news","type-news","status-publish","has-post-thumbnail","hentry","category-publications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN) - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN)\" \/>\n<meta property=\"og:description\" content=\"La r\u00e9mission a r\u00e9cemment \u00e9t\u00e9 propos\u00e9e comme nouvel objectif de prise en charge de la RSCaPN, ou syndrome des polypes nasaux, par l\u2019EUFOREA \/ le document de r\u00e9f\u00e9rence europ\u00e9en sur la rhinosinusite et les polypes nasaux (EUFOREA\/EPOS), ainsi que par des leaders mondiaux en rhinologie. Dans la RSCaPN, la r\u00e9mission est d\u00e9finie comme un \u00e9tat prolong\u00e9 de contr\u00f4le, sans sympt\u00f4mes g\u00eanants rapport\u00e9s par le patient pendant au moins 12 mois, sans recours aux corticost\u00e9ro\u00efdes oraux ni \u00e0 la chirurgie endoscopique des sinus (ESS), et sans signes endoscopiques de maladie active. Ce nouvel objectif de prise en charge doit \u00eatre encourag\u00e9 par la communaut\u00e9 ORL et les patients atteints de RSCaPN, car des sympt\u00f4mes persistants non soulag\u00e9s par les approches historiques peuvent \u00eatre r\u00e9duits gr\u00e2ce \u00e0 de nouvelles th\u00e9rapies, notamment les bioth\u00e9rapies. L\u2019objectif du traitement de la RSCaPN a longtemps \u00e9t\u00e9 d\u2019atteindre le contr\u00f4le, les scores de l\u2019\u00e9chelle visuelle analogique (EVA) et du Sino-Nasal Outcome Test (SNOT-22) guidant les m\u00e9decins vers un traitement progressif visant le contr\u00f4le. Co-auteurs : Peter Hellings. Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Acc\u00e8s libre en rhinologie\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T07:56:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1748\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/\",\"name\":\"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN) - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"datePublished\":\"2025-04-01T13:57:43+00:00\",\"dateModified\":\"2026-08-20T07:56:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN) - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN)","og_description":"La r\u00e9mission a r\u00e9cemment \u00e9t\u00e9 propos\u00e9e comme nouvel objectif de prise en charge de la RSCaPN, ou syndrome des polypes nasaux, par l\u2019EUFOREA \/ le document de r\u00e9f\u00e9rence europ\u00e9en sur la rhinosinusite et les polypes nasaux (EUFOREA\/EPOS), ainsi que par des leaders mondiaux en rhinologie. Dans la RSCaPN, la r\u00e9mission est d\u00e9finie comme un \u00e9tat prolong\u00e9 de contr\u00f4le, sans sympt\u00f4mes g\u00eanants rapport\u00e9s par le patient pendant au moins 12 mois, sans recours aux corticost\u00e9ro\u00efdes oraux ni \u00e0 la chirurgie endoscopique des sinus (ESS), et sans signes endoscopiques de maladie active. Ce nouvel objectif de prise en charge doit \u00eatre encourag\u00e9 par la communaut\u00e9 ORL et les patients atteints de RSCaPN, car des sympt\u00f4mes persistants non soulag\u00e9s par les approches historiques peuvent \u00eatre r\u00e9duits gr\u00e2ce \u00e0 de nouvelles th\u00e9rapies, notamment les bioth\u00e9rapies. L\u2019objectif du traitement de la RSCaPN a longtemps \u00e9t\u00e9 d\u2019atteindre le contr\u00f4le, les scores de l\u2019\u00e9chelle visuelle analogique (EVA) et du Sino-Nasal Outcome Test (SNOT-22) guidant les m\u00e9decins vers un traitement progressif visant le contr\u00f4le. Co-auteurs : Peter Hellings. Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Acc\u00e8s libre en rhinologie","og_url":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-20T07:56:57+00:00","og_image":[{"width":1748,"height":1015,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/","url":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/","name":"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN) - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","datePublished":"2025-04-01T13:57:43+00:00","dateModified":"2026-08-20T07:56:57+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/remission-dans-la-rhinosinusite-chronique-avec-polypes-nasaux-rscapn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"R\u00e9mission dans la rhinosinusite chronique avec polypes nasaux (RSCaPN)"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/25187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=25187"}],"version-history":[{"count":1,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/25187\/revisions"}],"predecessor-version":[{"id":25192,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/25187\/revisions\/25192"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/25189"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=25187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=25187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=25187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}